The development of programmable nucleases has enabled the application of new genome engineering strategies for cellular immunotherapy.
BigField GEG Tech's insight:
Here the authors show a proof-of-concept for reprogramming MHC-specificity by performing CRISPR-Cas9-assisted cassette exchange. Using murine antigen presenting cell lines (RAW264.7 macrophages), they demonstrate that the generation of Cas9-induced double-stranded breaks flanking the native MHC-I H2-Kd locus led to exchange of an orthogonal H2-Kb allele. These findings highlight a potential new approach for the correcting of MHC mismatches in cellular transplantation.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” cancer therapy.
The study was published in Nature Immunology.
https://www.nature.com/articles/s41590-019-0578-8